These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 34599680)
1. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer. Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680 [TBL] [Abstract][Full Text] [Related]
2. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
3. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Xu Y; Qiu A; Peng F; Tan X; Wang J; Gong X Neoplasma; 2021 Jan; 68(1):108-118. PubMed ID: 33147048 [TBL] [Abstract][Full Text] [Related]
4. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496 [TBL] [Abstract][Full Text] [Related]
6. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p. Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958 [TBL] [Abstract][Full Text] [Related]
7. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer. Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372 [TBL] [Abstract][Full Text] [Related]
8. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis. Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345 [TBL] [Abstract][Full Text] [Related]
9. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
10. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity. Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111 [TBL] [Abstract][Full Text] [Related]
11. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Liang H; Xu Y; Zhang Q; Yang Y; Mou Y; Gao Y; Chen R; Chen C; Dai P Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):725-736. PubMed ID: 30861353 [TBL] [Abstract][Full Text] [Related]
12. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530 [TBL] [Abstract][Full Text] [Related]
13. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer. Xu Y; Zhu M Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833 [TBL] [Abstract][Full Text] [Related]
14. miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. Zhou H; Lin C; Zhang Y; Zhang X; Zhang C; Zhang P; Xie X; Ren Z Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28217977 [TBL] [Abstract][Full Text] [Related]
15. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Wang H; Wang X; Zhang H; Deng T; Liu R; Liu Y; Li H; Bai M; Ning T; Wang J; Ge S; Ba Y Oncogene; 2021 Jul; 40(28):4695-4708. PubMed ID: 34140641 [TBL] [Abstract][Full Text] [Related]
16. SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA-20b-3p/DEPDC1 axis. Zhao B; Wang Y; Zhao X; Ni J; Zhu X; Fu Y; Yang F Cell Biol Int; 2022 Dec; 46(12):2107-2117. PubMed ID: 36200529 [TBL] [Abstract][Full Text] [Related]
17. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin. Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y Gene; 2024 Jul; 914():148406. PubMed ID: 38521111 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axis. Gao Y; Liu C; Xu X; Wang Y; Jiang Y Anticancer Drugs; 2022 Jul; 33(6):553-563. PubMed ID: 35276696 [TBL] [Abstract][Full Text] [Related]
19. Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer. Ning T; Li J; He Y; Zhang H; Wang X; Deng T; Liu R; Li H; Bai M; Fan Q; Zhu K; Ying G; Ba Y Mol Ther; 2021 Sep; 29(9):2723-2736. PubMed ID: 33905821 [TBL] [Abstract][Full Text] [Related]
20. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]